Free Trial

CME Group (NASDAQ:CME) General Counsel Sells $102,704.00 in Stock

CME Group logo with Finance background

Key Points

  • Jonathan Marcus, General Counsel of CME Group, sold 392 shares at an average price of $262.00, totaling $102,704.00, which decreased his ownership stake by 4.76%.
  • CME Group reported a 10.4% increase in revenue year-over-year, achieving $1.69 billion with earnings per share of $2.96, surpassing analysts' estimates.
  • The company plans to distribute a quarterly dividend of $1.25 per share, offering an annualized yield of 1.9% and a payout ratio of 48.40%.
  • MarketBeat previews top five stocks to own in October.

CME Group Inc. (NASDAQ:CME - Get Free Report) General Counsel Jonathan L. Marcus sold 392 shares of CME Group stock in a transaction that occurred on Thursday, September 18th. The stock was sold at an average price of $262.00, for a total value of $102,704.00. Following the transaction, the general counsel directly owned 7,851 shares in the company, valued at approximately $2,056,962. This trade represents a 4.76% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

CME Group Stock Up 0.2%

Shares of CME stock traded up $0.45 during mid-day trading on Monday, reaching $261.98. 70,032 shares of the company were exchanged, compared to its average volume of 2,279,557. The company has a market capitalization of $94.41 billion, a P/E ratio of 25.36, a P/E/G ratio of 4.73 and a beta of 0.43. The business's 50 day simple moving average is $271.98 and its 200 day simple moving average is $270.81. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a fifty-two week low of $212.60 and a fifty-two week high of $290.79.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, topping analysts' consensus estimates of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The company had revenue of $1.69 billion for the quarter, compared to the consensus estimate of $1.68 billion. During the same quarter in the previous year, the business earned $2.56 EPS. The company's quarterly revenue was up 10.4% compared to the same quarter last year. Research analysts predict that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th will be paid a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a dividend yield of 1.9%. The ex-dividend date of this dividend is Tuesday, September 9th. CME Group's dividend payout ratio is 48.40%.

Institutional Investors Weigh In On CME Group

Several institutional investors and hedge funds have recently bought and sold shares of CME. Jessup Wealth Management Inc grew its stake in CME Group by 0.5% in the second quarter. Jessup Wealth Management Inc now owns 7,969 shares of the financial services provider's stock worth $2,197,000 after purchasing an additional 36 shares during the period. First Horizon Advisors Inc. lifted its holdings in shares of CME Group by 0.7% in the 2nd quarter. First Horizon Advisors Inc. now owns 5,269 shares of the financial services provider's stock valued at $1,453,000 after buying an additional 36 shares during the period. Great Lakes Advisors LLC raised its holdings in shares of CME Group by 2.3% during the first quarter. Great Lakes Advisors LLC now owns 1,661 shares of the financial services provider's stock valued at $441,000 after acquiring an additional 37 shares during the last quarter. MBM Wealth Consultants LLC increased its stake in CME Group by 2.7% during the second quarter. MBM Wealth Consultants LLC now owns 1,422 shares of the financial services provider's stock worth $392,000 after acquiring an additional 37 shares during the last quarter. Finally, Beaumont Financial Advisors LLC boosted its holdings in CME Group by 2.0% in the second quarter. Beaumont Financial Advisors LLC now owns 1,952 shares of the financial services provider's stock valued at $538,000 after purchasing an additional 38 shares during the period. Institutional investors own 87.75% of the company's stock.

Analyst Ratings Changes

Several research firms have recently commented on CME. Barclays set a $298.00 price objective on shares of CME Group and gave the company an "equal weight" rating in a research note on Thursday, July 24th. Citigroup upped their price target on CME Group from $265.00 to $275.00 and gave the stock a "neutral" rating in a report on Thursday, July 3rd. Piper Sandler increased their price target on CME Group from $283.00 to $296.00 and gave the stock an "overweight" rating in a report on Tuesday, July 15th. UBS Group decreased their target price on CME Group from $305.00 to $285.00 and set a "neutral" rating on the stock in a research report on Monday, September 8th. Finally, Wall Street Zen downgraded CME Group from a "hold" rating to a "sell" rating in a research report on Sunday, July 13th. Four investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have given a Sell rating to the company. According to MarketBeat, CME Group presently has a consensus rating of "Hold" and a consensus price target of $260.60.

Read Our Latest Research Report on CME

CME Group Company Profile

(Get Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Articles

Insider Buying and Selling by Quarter for CME Group (NASDAQ:CME)

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.